These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3533793)

  • 1. Suppression and re-expression of transformed phenotype in hybrids of HA-ras-1-transformed rat-1 cells and early-passage rat embryonic fibroblasts.
    Griegel S; Traub O; Willecke K; Schäfer R
    Int J Cancer; 1986 Nov; 38(5):697-705. PubMed ID: 3533793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ha-ras-induced transformed phenotype of rat-1 cells can be suppressed in hybrids with rat embryonic fibroblasts.
    Willecke K; Griegel S; Martin W; Traub O; Schäfer R
    J Cell Biochem; 1987 May; 34(1):23-30. PubMed ID: 3495543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of tumorigenicity in hybrids of normal and oncogene-transformed CHEF cells.
    Craig RW; Sager R
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2062-6. PubMed ID: 3856884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.
    Geiser AG; Der CJ; Marshall CJ; Stanbridge EJ
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5209-13. PubMed ID: 3523486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of transformed phenotype in hybrids of v-fgr and v-raf transformed rat-1 cells with rat embryonic fibroblasts is due to transcriptional inactivation of viral oncogenes.
    Martin W; Lenz E; Grohé B; Willecke K
    Exp Cell Res; 1992 May; 200(1):41-7. PubMed ID: 1563491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of chromosome loss in ras/myc-induced Syrian hamster tumors.
    Oshimura M; Koi M; Ozawa N; Sugawara O; Lamb PW; Barrett JC
    Cancer Res; 1988 Mar; 48(6):1623-32. PubMed ID: 2449958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome losses in tumorigenic revertants of EJ/ras-expressing somatic cell hybrids.
    Pratt CI; Wu SQ; Bhattacharya M; Kao C; Gilchrist KW; Reznikoff CA
    Cancer Genet Cytogenet; 1992 Apr; 59(2):180-90. PubMed ID: 1316224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consequences of altered oncogene expression in rodent cells.
    Pragnell IB; Spandidos DA; Wilkie NM
    Proc R Soc Lond B Biol Sci; 1985 Oct; 226(1242):107-19. PubMed ID: 2866518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of tumorigenicity in somatic cell hybrids does not involve quantitative changes in transcription of cellular Ha-ras, Ki-ras, myc, and fos oncogenes.
    Schäfer R; Geisse S; Willecke K
    J Cell Biochem; 1987 May; 34(1):31-8. PubMed ID: 3584261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
    Storer RD; Allen HL; Kraynak AR; Bradley MO
    Oncogene; 1988 Feb; 2(2):141-7. PubMed ID: 3285293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene.
    Lebeau J; Le Chalony C; Prosperi MT; Goubin G
    Oncogene; 1991 Jul; 6(7):1125-32. PubMed ID: 1861862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage.
    Schäfer R; Hoffmann H; Willecke K
    Cancer Res; 1983 May; 43(5):2240-6. PubMed ID: 6831446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
    Benedict WF; Weissman BE; Mark C; Stanbridge EJ
    Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene.
    Newbold RF; Overell RW
    Nature; 1983 Aug 18-24; 304(5927):648-51. PubMed ID: 6877385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of normal homologous cells by a spontaneously activated Ha-ras oncogene.
    Schwartz SA; Shuler CF; Freebeck P
    Cancer Res; 1988 Jun; 48(12):3470-7. PubMed ID: 3285996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperation between the H-ras oncogene and a truncated derivative of the v-myb oncogene in transformation of hamster embryo fibroblasts.
    Merzak A; Dooghe Y; Pironin M; Perbal B; Vigier P
    Oncogene; 1992 Oct; 7(10):2031-9. PubMed ID: 1408144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analysis of tumorigenesis. XXXI: Retention of short arm of chromosome 3 in suppressed CHEF cell hybrids containing c-Ha-ras (EJ) gene.
    Craig RW; Gadi IK; Sager R
    Somat Cell Mol Genet; 1988 Jan; 14(1):41-53. PubMed ID: 3277292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical correlates of phenotypic reversion in interferon-treated mouse cells transformed by a human oncogene.
    Samid D; Chang EH; Friedman RM
    Biochem Biophys Res Commun; 1984 Feb; 119(1):21-8. PubMed ID: 6200112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.